Did you ever want to have your end user stay in MyTalk instead of accessing other programs on the iPad? Use Guided Access to make MyTalk the only app available on your iPad.
Scroll down to Accessibility
Tap 'Guided Access'
Turn Guided Access on
Now Tap 'Set Passcode'
Enter a 4 digit Passcode once, then you are asked to enter it again.
After entering your passcode two times
Tap the 'Accessibility' back button, then the device's home button to return to the main menu.
Within MyTalk, triple click the device home button and Select 'Guided Access'
Accept the default settings (at the bottom) and tap 'Start' at top right.
If your end user selects the device home button to close MyTalk and go somewhere else, they are met with the greeting below.
Even if your end user is high functioning, reads, understands and triple clicks the device home button.
They are met with the 'Enter Passcode' dialogue box. Bad entries in that box will give them the message below.
So let's just talk, with MyTalk and iPad a dedicated communication device. Make sure that your insurer understands as well as your end user. It's time to get funding for these wonderful low cost solutions.
Video example - Watch closely:
In the video below a user is working in MyTalk but then selects the device home button, navigating to the music app. We may not want that to happen.
Next you will see that we go to Settings (the gray gear icon) and walk through the steps above, enabling Guided Access.
Upon re-entering MyTalk the user starts a conversation but then selects the device home button. You are then presented the 'guided access' message and held in MyTalk.
In the 'guided access' message your end user is instructed to hit the idevice home button 3 times. The video assumes a high functioning end user and demonstrates following that instruction, selecting the device home button 3 times rapidly.
But as you see, they are presented the password dialogue box. From there the end user can guess, tapping the numbers or tap the cancel button. Both scenarios return him to MyTalk.
What does this mean for funding iPads and MyTalk?
Linkedin members, see Mark's comments in the Linked in Chat:
Non Linkedin Members, we have excerpted comments from the link above:
The link above and the excerpt below are the opinions of the writers. I have commented within the Linkedin string of notes. In the excerpt below I have removed some references to the traditional manufacturers that can be seen on the post, but were deleted from the MyTalk site as a courtesy.
|what are your thoughts on : the clinical reasons for an ipad compared with an android device in a Speech Language Therapy program to assist...|
|Based on 25 years of working with most dedicated SGD's, I truly don't believe it's the device that matters--it's far more about the way it's implemented and set up for the user. But, if you're talking about both AAC and speech-related therapy apps, iPad wins for the sheer volume of useful tools.
One of the major perks to the iPad solely for AAC is that thanks to prodding from the AT and autism communities, Apple now offers a setting so that you can turn the machine into a dedicated device by using its Guided Access tool to restrict the user's ability to exit the communication app. Because of this change, some state's Medicaid programs are now considering use of the machine as a dedicated system which means insurance billing is right around the corner--but only if we lobby for it. All dedicated devices from Dynavox, to Tobii, to PRC, GUS, etc., can be used as computing devices if you shut off their "dedicated control settings"--which means there is little difference between iPads and their devices now contrary to what those companies tell you. (Some comments deleted) This technical similarity between SGD's and tablets is what the tech-illiterate committees for Insurance and medicaid need to comprehend, and we need to teach them about it. Let's see, $8000 for a SGD or $600 for a tablet (plus amplifying case and app)--where would you like your taxes to go?
|By Mark Surabian|
Please sign in to leave a comment.